A progressive neurodegenerative disorder affecting movement, often treated with deep brain stimulation.Parkinson's disease is a progressive neurodegenerative disorder that primarily affects movement, causing tremors, stiffness, and difficulty with balance and coordination. It results from the gradual loss of dopamine-producing neurons in a brain region called the substantia nigra. The disease also involves non-motor symptoms like depression, sleep disturbances, and cognitive decline, making it a complex condition that affects quality of life profoundly.
The disease was first formally described in 1817 by James Parkinson in his essay 'An Essay on the Shaking Palsy'. The link to dopamine loss was established in the 1950s and 1960s by Arvid Carlsson and Oleh Hornykiewicz, leading to the development of levodopa therapy.
The loss of dopamine disrupts the normal signaling in the basal ganglia, a set of brain structures that help initiate and regulate movement. Without sufficient dopamine, the brain's motor circuits become overactive or underactive, leading to the characteristic symptoms. Treatments aim to restore dopamine levels (e.g., with levodopa) or to modulate the abnormal brain activity directly, as in deep brain stimulation, where electrodes implanted in specific brain regions deliver electrical pulses to normalize circuit function.
Deep brain stimulation is used to treat motor symptoms in advanced Parkinson's disease when medications become less effective, and research models are being developed to personalize treatment strategies.
The characteristic resting tremor in Parkinson's disease often disappears during voluntary movement, which is why patients can sometimes perform actions like catching a ball despite the shaking.






